MTND4P9

Across TCGA pan-cancer cohorts, MTND4P9 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated MTND4P9 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MTND4P9 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MTND4P9 expression acts as an unfavorable survival marker, although some lineages such as KIRC and SKCM show a favorable association.

KIRC, LIHC, and LAML are the cancer types where MTND4P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.707	0.548	<.001	144	view →
LIHC	OS	Tertile	II,III,IV	0.451	0.655	.003	51	view →
LAML	DFS	Median	All	0.457	0.678	.001	48	view →
ACC	DFS	Tertile	IV	0.010	0.383	<.001	45	view →
SKCM	DFS	Quartile	All	0.284	0.175	<.001	41	view →
LGG	DFS	Median	All	0.316	0.499	<.001	38	view →
KIRP	OS	Tertile	All	0.982	0.894	.011	36	view →
HNSC	DFS	Median	IV	0.702	0.582	.013	33	view →
BLCA	OS	Median	All	0.522	0.355	.007	27	view →
LUSC	DFS	Median	III,IV	0.139	0.784	<.001	25	view →
COAD	OS	Quartile	IV	0.798	0.380	.006	13	view →
PRAD	DFS	Tertile	All	0.894	0.662	.001	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

MTND4P9–KIRC (OS)

Open the KIRC breakdown →